TORONTO, ON, Canada, via ETELIGIS INC., 08/03/2015 – – Amfil Technologies Inc. (OTC Pink: AMFE) (PINKSHEETS: AMFE), provider of custom engineering and integration of ozone based technology for the medical marijuana manufacturing industry through the GROzone line of products, today announced that it has submitted a provisional patent application with the United States Patent & Trademark Office under the Patent Cooperation Treaty (PCT) encompassing the ozone technology and delivery system used in the GROzone gaseous and aqueous systems.
The provisional application allows the company to establish and ‘lock in’ an early effective filing date for any one or more continuing patent applications or modifications made in the future and later claim the priority date of this provisional application.
The PCT submission was assigned patent pending number PCT/US15/40303 by the USPTO.
The company will be making some exciting announcements in the near future regarding the GROzone and Interloc-Kings Inc. subsidiaries including current contracts and sales as well as third party lab results from the Today’s Health Care facility in Colorado comparing the GROzone 60 rooms product quality to a standard room. The year-end financials will be submitted in the coming weeks and the company expects and will be pleased to announce a continued double digit year over year percentage increase in revenue. Year end June 30th 2014 showed a 61% increase in revenues when compared to year end June 30th 2013 and the company expects to announce an even greater revenue percentage increase for year end June 30th 2015 compared to 2014.
RECENT COMPANY HIGHLIGHTS:
– Audited Financial Statement Submission & Unaudited OTC Markets Disclosure for Current Information
– Double digit percentage increase in revenues year over year
– Less than 5% increase in the outstanding share count over the past two years
– Public float with the DTC of 168,047,581 which is cumulative over the entire 30 year company history
– Recent inclusion on the MJIC Marijuana Index and Cannabis Financial Network Coverage.
– Successful Integration of the GROzone 60 System into Today’s Health Care (THC) Facility of Colorado
– Success within the operating subsidiaries. GROzone lab results & Interloc-Kings Contracts Coming Soon
– Patent Pending Status on GROzone technology
– Much more to come and to be disclosed shortly
About Amfil Technologies, Inc.
Amfil Technologies Inc. operates both the Interloc-Kings Inc. subsidiary as well as the GROzone Project. GROzone was jointly developed between Amfil Tech and A.C.T.S. Inc. as an extension of the existing mPACT ozone technology being utilized in the food and beverage industry and integrated by A.C.T.S. into companies such as Pepsi, Nestle, Sysco, Sun Pacific and many others. GROzone is a triple-function sanitization unit capable of naturally eliminating 99.9% of airborne pathogens and the typically problematic pests that wreak havoc for cultivators (like aphids, whiteflies and spider mites), as well as bacteria, fungus, microbes and mold on surfaces, all without chemicals. The unit can also constantly regulate a given facility’s water supply, oxygenating the water and maintaining a consistent PPM infusion of ozone that prevents the formation of algae, bacteria or mold (allowing for comprehensive water recycling), simultaneously removing the need to use dangerous, often carcinogenic products to treat the water, as is common throughout the industry today. This environmentally-friendly solution also eliminates odors, while slightly reducing the air temperature, lowering energy consumption by the HEPA filtration and HVAC systems. There is even compelling research indicating that elevated levels of ozone and CO2 can produce yields having as much as 53% more total biomass in certain plant types, with similar results for seed production. More information of the grozone line of products can be found on the www.grozone.biz website.
Safe Harbor Statement
This news release contains statements that involve expectations, plans or intentions (such as those relating to future business or financial results, new features or services, or management strategies) and other factors discussed from time to time in the Company’s Securities and Exchange Commission filings. These statements are forward-looking and are subject to risks and uncertainties, so actual results may vary materially. You can identify these forward-looking statements by words such as "may," "should," "expect," "anticipate," "believe," "estimate," "intend," "plan" and other similar expressions. Our actual results, such as the Company’s ability to finance, complete and consolidate acquisition of IP, assets and operating companies, could differ materially from those anticipated in these forward-looking statements as a result of certain factors not within the control of the company such as a result of various factors, including future economic, competitive, regulatory, and market conditions. The company cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. The company disclaims any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.
Roger Mortimer, President
Amfil Technologies Inc.
Telephone: (647) 880-5887
SOURCE: Amfil Technologies Inc.